Addressing Unmet Cardiovascular Needs
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions, affect large patient populations and drive a significant portion of healthcare costs. Our main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year or 31% of all global deaths according to the World Health Organization. Cardiovascular diseases are the leading cause of death in the U.S. as well, causing 774,165 deaths or over 28.5% of all deaths in 2015 according to the CDC. Despite medical advancements, there remains significant need for improvement in clinical outcomes associated with cardiovascular disease.
[ 17.7M people die every year from cardiovascular diseases ]
